ArrowMark Colorado Holdings LLC grew its holdings in Tcr2 Therapeutics Inc (NASDAQ:TCRR) by 12.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,269,766 shares of the company’s stock after purchasing an additional 143,459 shares during the quarter. ArrowMark Colorado Holdings LLC […]